Improving Heart Function

19/08/2026

🔎 Tricuspid Regurgitation in Heart Failure: when is it time to act?

Join Marianna Adamo, Marta Sitges, Marina Urena, Giuseppe Rosano and Mirjam Wild for a practical expert discussion covering:
- When to suspect TR progression
- When to worry about right-heart deterioration
- When to consider referral and intervention

📅 Thursday 3 September 2026 I 5:00 PM (UTC+2)
💻 Online I Free registration

👉 Register now: https://brnw.ch/21x539b

Organized in collaboration with the PCRonline Tricuspid Focus Group.

14/07/2026

🔎 Could home-based decongestion redefine the management of worsening heart failure?

Presented at HFA 2026, the SUBCUT-HF II trial explores whether early discharge with an ambulatory, patient-managed subcutaneous furosemide pump can optimize heart failure care.

In this new Trial Review, Jan Biegus reviews the evidence and explores the potential of this innovative home-based decongestion strategy for patients with worsening heart failure.

Watch the full review: https://brnw.ch/21x482J

Jan Biegus reviews the SUBCUT-HF II trial, evaluating whether early discharge combined with an ambulatory subcutaneous furosemide pump safely improves out-of-hospital days for heart failure patients compared to standard care.

10/07/2026

👀 Do you remember the case of a 39-year-old patient presented with a late STEMI complicated by severe biventricular dysfunction and a non-restrictive ventricular septal defect (VSD) rapidly requiring peripheral VA-ECMO and IABP support?

Faced with this life-threatening scenario, opinion was highly divided among respondents. Discover now the Heart Team's strategy to manage this major mechanical complication.

👉 Read the Part 2: https://brnw.ch/21x41ja

Share your thoughts in the comments!

09/07/2026

🫀 or ? The answer isn't always straightforward.

For patients with and chronic coronary syndromes, choosing the optimal revascularisation strategy goes far beyond coronary anatomy.

In this excerpt from our last iHF Webinar, experts discuss the respective roles of CABG and PCI, the importance of achieving complete revascularisation, and why every complex case should be reviewed by a multidisciplinary Heart Team.

🎥 Watch the full webinar on the iHF website to explore the complete clinical case and the latest evidence guiding decision-making: https://www.iheartfunction.com/webinars/hfref-and-chronic-coronary-syndromes-guided-directed-medical-therapy-optimal

01/07/2026

🎥 Missed our latest webinar? The replay is now available!

Catch up with this free iHF webinar on HFrEF and chronic coronary syndromes, featuring a multidisciplinary Heart Team discussion based on a real-world patient case.

Gain practical insights into:
- Selecting patients with HFrEF and CAD who may benefit from revascularisation
- Choosing between PCI and CABG
- Optimising guideline-directed medical therapy following revascularisation

🔗 Watch the free replay: https://brnw.ch/21x3NA9

30/06/2026

🫀 Can therapy redefine treatment for a specific phenotype?

Published in Circulation, the PRAISE-MR trial explores whether sacubitril/valsartan can improve haemodynamics, exercise capacity and atrial functional mitral regurgitation in patients with HFpEF.

In this new Journal Club, Jolie Bruno reviews the study, highlights its key findings, and discusses what they could mean for the management of HFpEF in clinical practice.

📖 Read here:
https://www.iheartfunction.com/news/angiotensin-receptor-neprilysin-inhibitor-heart-failure-preserved-ejection-fraction

25/06/2026

🫀 Post-MI ventricular septual rupture: a critical trans-disciplinary case

A 39-year-old patient with no medical history presented with a late STEMI, severe biventricular dysfunction, and a non-restrictive ventricular septal defect (VSD).
Despite urgent PCI and IABP support, his condition quickly deteriorated, with severe lactic acidosis and pulmonary oedema. Intubated and transferred to a hub centre, he required peripheral VA-ECMO rescue.

How would you manage this post-MI mechanical complication?

👉 Read the case and vote: https://brnw.ch/21x3Eej

22/06/2026

How can GDMT and MCS devices optimize the management of patients with advanced heart failure?

🎥 Hear key insights from Daniel Burkhoff and Alexandre Mebazaa, and catch up with this 2026 case-based session on our website.

🔗 Watch the replay: https://brnw.ch/21x3xVS

18/06/2026

⏳ This Friday: Don’t miss our iHF webinar on HFrEF and CCS

Join us for a live discussion dedicated to one of the most challenging areas in contemporary cardiovascular care: the management of patients with HFrEF and CCS.

📅 19 June 2026 | 17:30 - 18:30 (UTC+2)

👉 Register online now: https://brnw.ch/21x3rqC

Expert panel: Martine Gilard, Sabine Bleiziffer, Marta Belmonte, Emiliano Fiori, Ahmed Bennis and Amina Rakisheva.

17/06/2026

👀 Alexandre Mebazaa has a message for you...

Join us on Friday for an webinar and discover the latest advances in optimising care for patients with and , presented by a trans-disciplinary team of experts.

📆 June 19 I 17:30 (UCT+2)

👉 Register now: https://lnkd.in/dbJbDW4e